Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 30 entries
Sorted by: Best Match Show Resources per page
Double-blind acupuncture needle: a potential tool to investigate the nature of pain and pleasure.

ISRN Pain

Takakura N, Takayama M, Kawase A, Kaptchuk TJ, Yajima H.
PMID: 24288658
ISRN Pain. 2013;2013. doi: 10.1155/2013/825751.

BACKGROUND: Most of our knowledge about similarities in the neural processing of painful and pleasant sensations in the brain derives from studying each phenomenon separately. Patients often feel pain induced by acupuncture, which is noxious stimulation having the symbolic...

Cite
Takakura N, Takayama M, Kawase A, et al. Double-blind acupuncture needle: a potential tool to investigate the nature of pain and pleasure. ISRN Pain. 2013;2013doi: 10.1155/2013/825751.
Takakura, N., Takayama, M., Kawase, A., Kaptchuk, T. J., & Yajima, H. (2013). Double-blind acupuncture needle: a potential tool to investigate the nature of pain and pleasure. ISRN Pain, 2013. https://doi.org/10.1155/2013/825751
Takakura, Nobuari, et al. "Double-blind acupuncture needle: a potential tool to investigate the nature of pain and pleasure." ISRN Pain vol. 2013 (2013). doi: https://doi.org/10.1155/2013/825751
Takakura N, Takayama M, Kawase A, Kaptchuk TJ, Yajima H. Double-blind acupuncture needle: a potential tool to investigate the nature of pain and pleasure. ISRN Pain. 2013;2013. doi: 10.1155/2013/825751. PMID: 24288658; PMCID: PMC3839571.
Copy Download .nbib Format: NLM
Network analysis of the genomic basis of the placebo effect.

JCI insight

Wang RS, Hall KT, Giulianini F, Passow D, Kaptchuk TJ, Loscalzo J.
PMID: 28570268
JCI Insight. 2017 Jun 02;2(11). doi: 10.1172/jci.insight.93911. eCollection 2017 Jun 02.

The placebo effect is a phenomenon in which patients who are given an inactive treatment (e.g., inert pill) show a perceived or actual improvement in a medical condition. Placebo effects in clinical trials have been investigated for many years...

Cite
Wang RS, Hall KT, Giulianini F, et al. Network analysis of the genomic basis of the placebo effect. JCI Insight. 2017;2(11)doi: 10.1172/jci.insight.93911.
Wang, R. S., Hall, K. T., Giulianini, F., Passow, D., Kaptchuk, T. J., & Loscalzo, J. (2017). Network analysis of the genomic basis of the placebo effect. JCI insight, 2(11), . https://doi.org/10.1172/jci.insight.93911
Wang, Rui-Sheng, et al. "Network analysis of the genomic basis of the placebo effect." JCI insight vol. 2,11 (2017). doi: https://doi.org/10.1172/jci.insight.93911
Wang RS, Hall KT, Giulianini F, Passow D, Kaptchuk TJ, Loscalzo J. Network analysis of the genomic basis of the placebo effect. JCI Insight. 2017 Jun 02;2(11). doi: 10.1172/jci.insight.93911. eCollection 2017 Jun 02. PMID: 28570268; PMCID: PMC5453712.
Copy Download .nbib Format: NLM
Distant healing.

Annals of internal medicine

Kaptchuk TJ.
PMID: 11255536
Ann Intern Med. 2001 Mar 20;134(6):532-3. doi: 10.7326/0003-4819-134-6-200103200-00025.

No abstract available.

Cite
Kaptchuk TJ. Distant healing. Ann Intern Med. 2001;134(6):532-3doi: 10.7326/0003-4819-134-6-200103200-00025.
Kaptchuk, T. J. (2001). Distant healing. Annals of internal medicine, 134(6), 532-3. https://doi.org/10.7326/0003-4819-134-6-200103200-00025
Kaptchuk, T J. "Distant healing." Annals of internal medicine vol. 134,6 (2001): 532-3. doi: https://doi.org/10.7326/0003-4819-134-6-200103200-00025
Kaptchuk TJ. Distant healing. Ann Intern Med. 2001 Mar 20;134(6):532-3. doi: 10.7326/0003-4819-134-6-200103200-00025. PMID: 11255536.
Copy Download .nbib Format: NLM
Structural integration as an adjunct to outpatient rehabilitation for chronic nonspecific low back pain: a randomized pilot clinical trial.

Evidence-based complementary and alternative medicine : eCAM

Jacobson EE, Meleger AL, Bonato P, Wayne PM, Langevin HM, Kaptchuk TJ, Davis RB.
PMID: 25945112
Evid Based Complement Alternat Med. 2015;2015:813418. doi: 10.1155/2015/813418. Epub 2015 Apr 07.

Structural Integration (SI) is an alternative method of manipulation and movement education. To obtain preliminary data on feasibility, effectiveness, and adverse events (AE), 46 outpatients from Boston area with chronic nonspecific low back pain (CNSLBP) were randomized to parallel...

Cite
Jacobson EE, Meleger AL, Bonato P, et al. Structural integration as an adjunct to outpatient rehabilitation for chronic nonspecific low back pain: a randomized pilot clinical trial. Evid Based Complement Alternat Med. 2015;2015:813418doi: 10.1155/2015/813418.
Jacobson, E. E., Meleger, A. L., Bonato, P., Wayne, P. M., Langevin, H. M., Kaptchuk, T. J., & Davis, R. B. (2015). Structural integration as an adjunct to outpatient rehabilitation for chronic nonspecific low back pain: a randomized pilot clinical trial. Evidence-based complementary and alternative medicine : eCAM, 2015813418. https://doi.org/10.1155/2015/813418
Jacobson, Eric E, et al. "Structural integration as an adjunct to outpatient rehabilitation for chronic nonspecific low back pain: a randomized pilot clinical trial." Evidence-based complementary and alternative medicine : eCAM vol. 2015 (2015): 813418. doi: https://doi.org/10.1155/2015/813418
Jacobson EE, Meleger AL, Bonato P, Wayne PM, Langevin HM, Kaptchuk TJ, Davis RB. Structural integration as an adjunct to outpatient rehabilitation for chronic nonspecific low back pain: a randomized pilot clinical trial. Evid Based Complement Alternat Med. 2015;2015:813418. doi: 10.1155/2015/813418. Epub 2015 Apr 07. PMID: 25945112; PMCID: PMC4405211.
Copy Download .nbib Format: NLM
Author Correction: Distinct thalamocortical network dynamics are associated with the pathophysiology of chronic low back pain.

Nature communications

Tu Y, Fu Z, Mao C, Falahpour M, Gollub RL, Park J, Wilson G, Napadow V, Gerber J, Chan ST, Edwards RR, Kaptchuk TJ, Liu T, Calhoun V, Rosen B, Kong J.
PMID: 32843661
Nat Commun. 2020 Aug 25;11(1):4347. doi: 10.1038/s41467-020-18191-4.

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Cite
Tu Y, Fu Z, Mao C, et al. Author Correction: Distinct thalamocortical network dynamics are associated with the pathophysiology of chronic low back pain. Nat Commun. 2020;11(1):4347doi: 10.1038/s41467-020-18191-4.
Tu, Y., Fu, Z., Mao, C., Falahpour, M., Gollub, R. L., Park, J., Wilson, G., Napadow, V., Gerber, J., Chan, S. T., Edwards, R. R., Kaptchuk, T. J., Liu, T., Calhoun, V., Rosen, B., & Kong, J. (2020). Author Correction: Distinct thalamocortical network dynamics are associated with the pathophysiology of chronic low back pain. Nature communications, 11(1), 4347. https://doi.org/10.1038/s41467-020-18191-4
Tu, Yiheng, et al. "Author Correction: Distinct thalamocortical network dynamics are associated with the pathophysiology of chronic low back pain." Nature communications vol. 11,1 (2020): 4347. doi: https://doi.org/10.1038/s41467-020-18191-4
Tu Y, Fu Z, Mao C, Falahpour M, Gollub RL, Park J, Wilson G, Napadow V, Gerber J, Chan ST, Edwards RR, Kaptchuk TJ, Liu T, Calhoun V, Rosen B, Kong J. Author Correction: Distinct thalamocortical network dynamics are associated with the pathophysiology of chronic low back pain. Nat Commun. 2020 Aug 25;11(1):4347. doi: 10.1038/s41467-020-18191-4. PMID: 32843661; PMCID: PMC7447812.
Copy Download .nbib Format: NLM
"Honorable Toward Your Whole Self": Experiences of the Body in Fatigued Breast Cancer Survivors.

Frontiers in psychology

Penner C, Zimmerman C, Conboy L, Kaptchuk T, Kerr C.
PMID: 32719641
Front Psychol. 2020 Jul 03;11:1502. doi: 10.3389/fpsyg.2020.01502. eCollection 2020.

INTRODUCTION: Cancer Related Fatigue (CRF) is one of the most common and detrimental side effects of cancer treatment. Despite its increasing prevalence and severity CRF remains dismissed by the majority of clinicians. One reason for the apparent gap between...

Cite
Penner C, Zimmerman C, Conboy L, et al. "Honorable Toward Your Whole Self": Experiences of the Body in Fatigued Breast Cancer Survivors. Front Psychol. 2020;11:1502doi: 10.3389/fpsyg.2020.01502.
Penner, C., Zimmerman, C., Conboy, L., Kaptchuk, T., & Kerr, C. (2020). "Honorable Toward Your Whole Self": Experiences of the Body in Fatigued Breast Cancer Survivors. Frontiers in psychology, 111502. https://doi.org/10.3389/fpsyg.2020.01502
Penner, Cooper, et al. ""Honorable Toward Your Whole Self": Experiences of the Body in Fatigued Breast Cancer Survivors." Frontiers in psychology vol. 11 (2020): 1502. doi: https://doi.org/10.3389/fpsyg.2020.01502
Penner C, Zimmerman C, Conboy L, Kaptchuk T, Kerr C. "Honorable Toward Your Whole Self": Experiences of the Body in Fatigued Breast Cancer Survivors. Front Psychol. 2020 Jul 03;11:1502. doi: 10.3389/fpsyg.2020.01502. eCollection 2020. PMID: 32719641; PMCID: PMC7350261.
Copy Download .nbib Format: NLM
Improving Medication Tolerance: A Pilot Study in Disorders of Gut-brain Interaction Treated With Tricyclic Antidepressants.

Journal of clinical gastroenterology

Ballou S, Iturrino J, Rangan V, Cheng V, Kelley JM, Lembo A, Kaptchuk TJ, Nee J.
PMID: 34091518
J Clin Gastroenterol. 2021 Jun 07; doi: 10.1097/MCG.0000000000001575. Epub 2021 Jun 07.

OBJECTIVES: Tricyclic antidepressants (TCAs) are commonly used to treat disorders of gut-brain interaction (DGBI). However, these medications are often associated with side effects that lead to early treatment discontinuation. Research in other chronic medical conditions suggests that many TCA...

Cite
Ballou S, Iturrino J, Rangan V, et al. Improving Medication Tolerance: A Pilot Study in Disorders of Gut-brain Interaction Treated With Tricyclic Antidepressants. J Clin Gastroenterol. 2021;doi: 10.1097/MCG.0000000000001575.
Ballou, S., Iturrino, J., Rangan, V., Cheng, V., Kelley, J. M., Lembo, A., Kaptchuk, T. J., & Nee, J. (2021). Improving Medication Tolerance: A Pilot Study in Disorders of Gut-brain Interaction Treated With Tricyclic Antidepressants. Journal of clinical gastroenterology, . https://doi.org/10.1097/MCG.0000000000001575
Ballou, Sarah, et al. "Improving Medication Tolerance: A Pilot Study in Disorders of Gut-brain Interaction Treated With Tricyclic Antidepressants." Journal of clinical gastroenterology vol. (2021). doi: https://doi.org/10.1097/MCG.0000000000001575
Ballou S, Iturrino J, Rangan V, Cheng V, Kelley JM, Lembo A, Kaptchuk TJ, Nee J. Improving Medication Tolerance: A Pilot Study in Disorders of Gut-brain Interaction Treated With Tricyclic Antidepressants. J Clin Gastroenterol. 2021 Jun 07; doi: 10.1097/MCG.0000000000001575. Epub 2021 Jun 07. PMID: 34091518.
Copy Download .nbib Format: NLM
Frequency of Adverse Events in the Placebo Arms of COVID-19 Vaccine Trials: A Systematic Review and Meta-analysis.

JAMA network open

Haas JW, Bender FL, Ballou S, Kelley JM, Wilhelm M, Miller FG, Rief W, Kaptchuk TJ.
PMID: 35040967
JAMA Netw Open. 2022 Jan 04;5(1):e2143955. doi: 10.1001/jamanetworkopen.2021.43955.

IMPORTANCE: Adverse events (AEs) after placebo treatment are common in randomized clinical drug trials. Systematic evidence regarding these nocebo responses in vaccine trials is important for COVID-19 vaccination worldwide especially because concern about AEs is reported to be a...

Cite
Haas JW, Bender FL, Ballou S, et al. Frequency of Adverse Events in the Placebo Arms of COVID-19 Vaccine Trials: A Systematic Review and Meta-analysis. JAMA Netw Open. 2022;5(1):e2143955doi: 10.1001/jamanetworkopen.2021.43955.
Haas, J. W., Bender, F. L., Ballou, S., Kelley, J. M., Wilhelm, M., Miller, F. G., Rief, W., & Kaptchuk, T. J. (2022). Frequency of Adverse Events in the Placebo Arms of COVID-19 Vaccine Trials: A Systematic Review and Meta-analysis. JAMA network open, 5(1), e2143955. https://doi.org/10.1001/jamanetworkopen.2021.43955
Haas, Julia W, et al. "Frequency of Adverse Events in the Placebo Arms of COVID-19 Vaccine Trials: A Systematic Review and Meta-analysis." JAMA network open vol. 5,1 (2022): e2143955. doi: https://doi.org/10.1001/jamanetworkopen.2021.43955
Haas JW, Bender FL, Ballou S, Kelley JM, Wilhelm M, Miller FG, Rief W, Kaptchuk TJ. Frequency of Adverse Events in the Placebo Arms of COVID-19 Vaccine Trials: A Systematic Review and Meta-analysis. JAMA Netw Open. 2022 Jan 04;5(1):e2143955. doi: 10.1001/jamanetworkopen.2021.43955. PMID: 35040967.
Copy Download .nbib Format: NLM
Manipulating placebo analgesia and nocebo hyperalgesia by changing brain excitability.

Proceedings of the National Academy of Sciences of the United States of America

Tu Y, Wilson G, Camprodon J, Dougherty DD, Vangel M, Benedetti F, Kaptchuk TJ, Gollub RL, Kong J.
PMID: 33941677
Proc Natl Acad Sci U S A. 2021 May 11;118(19). doi: 10.1073/pnas.2101273118.

Harnessing placebo and nocebo effects has significant implications for research and medical practice. Placebo analgesia and nocebo hyperalgesia, the most well-studied placebo and nocebo effects, are thought to initiate from the dorsal lateral prefrontal cortex (DLPFC) and then trigger...

Cite
Tu Y, Wilson G, Camprodon J, et al. Manipulating placebo analgesia and nocebo hyperalgesia by changing brain excitability. Proc Natl Acad Sci U S A. 2021;118(19)doi: 10.1073/pnas.2101273118.
Tu, Y., Wilson, G., Camprodon, J., Dougherty, D. D., Vangel, M., Benedetti, F., Kaptchuk, T. J., Gollub, R. L., & Kong, J. (2021). Manipulating placebo analgesia and nocebo hyperalgesia by changing brain excitability. Proceedings of the National Academy of Sciences of the United States of America, 118(19), . https://doi.org/10.1073/pnas.2101273118
Tu, Yiheng, et al. "Manipulating placebo analgesia and nocebo hyperalgesia by changing brain excitability." Proceedings of the National Academy of Sciences of the United States of America vol. 118,19 (2021). doi: https://doi.org/10.1073/pnas.2101273118
Tu Y, Wilson G, Camprodon J, Dougherty DD, Vangel M, Benedetti F, Kaptchuk TJ, Gollub RL, Kong J. Manipulating placebo analgesia and nocebo hyperalgesia by changing brain excitability. Proc Natl Acad Sci U S A. 2021 May 11;118(19). doi: 10.1073/pnas.2101273118. PMID: 33941677; PMCID: PMC8126770.
Copy Download .nbib Format: NLM
A 4-Month Whole-Systems Ayurvedic Medicine Nutrition and Lifestyle Intervention Is Feasible and Acceptable for Breast Cancer Survivors: Results of a Single-Arm Pilot Clinical Trial.

Global advances in health and medicine

Dhruva A, Wu C, Miaskowski C, Hartogensis W, Rugo HS, Adler SR, Kaptchuk TJ, Kelkar R, Agarawal S, Vadodaria A, Garris E, Hecht FM.
PMID: 33312762
Glob Adv Health Med. 2020 Dec 01;9:2164956120964712. doi: 10.1177/2164956120964712. eCollection 2020.

PURPOSE: Ongoing symptoms and impairments in quality of life (QOL) among breast cancer survivors remain a significant problem. We tested the feasibility and acceptability of a manualized Ayurvedic nutrition and lifestyle intervention for breast cancer survivors.METHODS: Eligible participants had...

Cite
Dhruva A, Wu C, Miaskowski C, et al. A 4-Month Whole-Systems Ayurvedic Medicine Nutrition and Lifestyle Intervention Is Feasible and Acceptable for Breast Cancer Survivors: Results of a Single-Arm Pilot Clinical Trial. Glob Adv Health Med. 2020;9:2164956120964712doi: 10.1177/2164956120964712.
Dhruva, A., Wu, C., Miaskowski, C., Hartogensis, W., Rugo, H. S., Adler, S. R., Kaptchuk, T. J., Kelkar, R., Agarawal, S., Vadodaria, A., Garris, E., & Hecht, F. M. (2020). A 4-Month Whole-Systems Ayurvedic Medicine Nutrition and Lifestyle Intervention Is Feasible and Acceptable for Breast Cancer Survivors: Results of a Single-Arm Pilot Clinical Trial. Global advances in health and medicine, 92164956120964712. https://doi.org/10.1177/2164956120964712
Dhruva, Anand, et al. "A 4-Month Whole-Systems Ayurvedic Medicine Nutrition and Lifestyle Intervention Is Feasible and Acceptable for Breast Cancer Survivors: Results of a Single-Arm Pilot Clinical Trial." Global advances in health and medicine vol. 9 (2020): 2164956120964712. doi: https://doi.org/10.1177/2164956120964712
Dhruva A, Wu C, Miaskowski C, Hartogensis W, Rugo HS, Adler SR, Kaptchuk TJ, Kelkar R, Agarawal S, Vadodaria A, Garris E, Hecht FM. A 4-Month Whole-Systems Ayurvedic Medicine Nutrition and Lifestyle Intervention Is Feasible and Acceptable for Breast Cancer Survivors: Results of a Single-Arm Pilot Clinical Trial. Glob Adv Health Med. 2020 Dec 01;9:2164956120964712. doi: 10.1177/2164956120964712. eCollection 2020. PMID: 33312762; PMCID: PMC7716077.
Copy Download .nbib Format: NLM
In the name of medicine.

Annals of internal medicine

Kaptchuk TJ.
PMID: 9758588
Ann Intern Med. 1998 Oct 01;129(7):589. doi: 10.7326/0003-4819-129-7-199810010-00022.

No abstract available.

Cite
Kaptchuk TJ. In the name of medicine. Ann Intern Med. 1998;129(7):589doi: 10.7326/0003-4819-129-7-199810010-00022.
Kaptchuk, T. J. (1998). In the name of medicine. Annals of internal medicine, 129(7), 589. https://doi.org/10.7326/0003-4819-129-7-199810010-00022
Kaptchuk, T J. "In the name of medicine." Annals of internal medicine vol. 129,7 (1998): 589. doi: https://doi.org/10.7326/0003-4819-129-7-199810010-00022
Kaptchuk TJ. In the name of medicine. Ann Intern Med. 1998 Oct 01;129(7):589. doi: 10.7326/0003-4819-129-7-199810010-00022. PMID: 9758588.
Copy Download .nbib Format: NLM
Conditioning open-label placebo: a pilot pharmacobehavioral approach for opioid dose reduction and pain control.

Pain reports

Morales-Quezada L, Mesia-Toledo I, Estudillo-Guerra A, O'Connor KC, Schneider JC, Sohn DJ, Crandell DM, Kaptchuk T, Zafonte R.
PMID: 32766465
Pain Rep. 2020 Jul 20;5(4):e828. doi: 10.1097/PR9.0000000000000828. eCollection 2020.

Opioid consumption for those in comprehensive inpatient rehabilitation units is high because of the complexity of their injuries. Notably, pain in rehabilitation leads to worsened clinical outcomes because of maladaptive behaviors and poor engagement during therapies. It is critical...

Cite
Morales-Quezada L, Mesia-Toledo I, Estudillo-Guerra A, et al. Conditioning open-label placebo: a pilot pharmacobehavioral approach for opioid dose reduction and pain control. Pain Rep. 2020;5(4):e828doi: 10.1097/PR9.0000000000000828.
Morales-Quezada, L., Mesia-Toledo, I., Estudillo-Guerra, A., O'Connor, K. C., Schneider, J. C., Sohn, D. J., Crandell, D. M., Kaptchuk, T., & Zafonte, R. (2020). Conditioning open-label placebo: a pilot pharmacobehavioral approach for opioid dose reduction and pain control. Pain reports, 5(4), e828. https://doi.org/10.1097/PR9.0000000000000828
Morales-Quezada, Leon, et al. "Conditioning open-label placebo: a pilot pharmacobehavioral approach for opioid dose reduction and pain control." Pain reports vol. 5,4 (2020): e828. doi: https://doi.org/10.1097/PR9.0000000000000828
Morales-Quezada L, Mesia-Toledo I, Estudillo-Guerra A, O'Connor KC, Schneider JC, Sohn DJ, Crandell DM, Kaptchuk T, Zafonte R. Conditioning open-label placebo: a pilot pharmacobehavioral approach for opioid dose reduction and pain control. Pain Rep. 2020 Jul 20;5(4):e828. doi: 10.1097/PR9.0000000000000828. eCollection 2020. PMID: 32766465; PMCID: PMC7373570.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 30 entries